Immuneering Corporation
IMRX | NASDAQ
$4.64
+$0.20 (+4.50%)
Sep 22, 2026, 11:27 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 455 | 38.84K | 133.25K | 316.95K | 506.09K | 949.84K | 1.52M | 2.08M | 2.56M | 2.76M | 2.58M |
Cost of Revenue | 793.21K | 793.21K | 612.73K | 174.65K | 174.65K | 174.65K | 174.65K | 185.22K | 185.22K | 378.73K | 378.73K | 193.51K | 212.85K | 269.63K | 360.48K | 566.7K | 766.45K | 834.76K | 1.15M | 1.42M | 1.52M | 1.43M |
Gross Profit | -793.21K | -793.21K | -612.73K | -174.65K | -174.65K | -174.65K | -174.65K | -185.22K | -185.22K | -378.73K | -378.73K | -193.06K | -174.02K | -136.38K | -43.53K | -60.61K | 183.39K | 680.7K | 926.89K | 1.14M | 1.24M | 1.14M |
Operating Income | -63.47M | -59.23M | -59.38M | -64.18M | -64.07M | -64.23M | -64.07M | -61.82M | -60.47M | -59.06M | -58.41M | -56.1M | -55.36M | -53.5M | -51.74M | -48.88M | -44.23M | -40.58M | -33.89M | -28.61M | -24.46M | -20.08M |
Interest Income | -410.7M | -411.45M | -412.38M | 1.59M | 1.72M | 2.23M | 2.59M | 2.93M | 3.24M | 3.58M | 3.61M | 3.37M | 2.74M | 1.71M | 1.01M | 641.18K | 435.59K | 296.05K | 169.9K | 27.53K | 11.28K | 10.49K |
Pretax Income | -57.28M | -54.44M | -56.02M | -62.5M | -62.13M | -61.78M | -61.04M | -58.07M | -56.07M | -54.18M | -53.39M | -51.55M | -51.8M | -51.14M | -50.51M | -48.36M | -44.05M | -40.51M | -33.84M | -28.59M | -24.45M | -20.07M |
Net Income | -57.28M | -54.44M | -56.02M | -62.5M | -62.13M | -61.77M | -61.04M | -58.07M | -56.07M | -54.18M | -53.47M | -51.63M | -51.88M | -51.22M | -50.51M | -48.05M | -43.74M | -40.2M | -33.54M | -28.59M | -24.45M | -20.07M |
Selling & General & Admin | 4.7B | 4.7B | 17.32M | 16.39M | 15.9M | 15.86M | 15.97M | 16.65M | 16.5M | 16.17M | 16.43M | 16.27M | 16.24M | 15.87M | 15.44M | 14.48M | 13.25M | 11.04M | 8.27M | 6.26M | 4.36M | 3.65M |
Research & Development | 10.68B | 10.68B | 42.11M | 47.59M | 47.97M | 48.17M | 47.9M | 44.96M | 43.76M | 42.5M | 41.51M | 39.53M | 38.84M | 37.39M | 36.24M | 34.31M | 31.16M | 30.21M | 26.54M | 23.48M | 21.34M | 17.57M |
Other Expenses | -15.31B | -15.31B | -661.9K | 22.42K | 21.59K | 21.65K | 22.02K | 22.02K | 22.27K | 14.48K | 94.79K | 101.49K | 101.7K | 101.7K | 22.02K | 15.32K | 7.91K | 8.31K | 361 | 361 | 421 | 23 |
Operating Expenses | 62.68M | 58.43M | 58.76M | 64.01M | 63.9M | 64.06M | 63.9M | 61.63M | 60.28M | 58.68M | 58.03M | 55.9M | 55.18M | 53.36M | 51.7M | 48.82M | 44.41M | 41.26M | 34.81M | 29.74M | 25.7M | 21.22M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 63.47M | 59.23M | 59.38M | 64.18M | 64.07M | 64.23M | 64.07M | 61.82M | 60.47M | 59.06M | 58.41M | 56.1M | 55.4M | 53.63M | 52.06M | 49.38M | 45.18M | 42.09M | 35.97M | 31.16M | 27.22M | 22.66M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -307.49K | -307.49K | -307.49K | -307.49K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 64.7M | 64.66M | 64.59M | 39.67M | 35.99M | 35.53M | 31.05M | 29.84M | 29.65M | 29.37M | 29.27M | 29.27M | 28.65M | 26.44M | 26.41M | 26.39M | 26.39M | 26.36M | 25.98M | 18.29M | 23.89M | 13.51M |
Shares Outstanding (Diluted) | 64.7M | 64.66M | 64.59M | 39.67M | 35.99M | 35.53M | 31.05M | 29.84M | 29.65M | 29.37M | 29.27M | 29.27M | 28.65M | 26.44M | 26.41M | 26.39M | 26.39M | 26.36M | 25.98M | 18.29M | 23.89M | 13.51M |
EPS (Basic) | -1.04 | -1.17 | -1.38 | -1.78 | -1.89 | -1.96 | -2.03 | -1.97 | -1.91 | -1.87 | 38.78 | 38.83 | 38.79 | 38.78 | -1.87 | -1.82 | -1.82 | -1.71 | -1.68 | -1.69 | -1.55 | -1.49 |
EPS (Diluted) | -1.04 | -1.17 | -1.38 | -1.78 | -1.89 | -1.96 | -2.03 | -1.97 | -1.91 | -1.87 | 38.78 | 38.83 | 38.79 | 38.78 | -1.87 | -1.82 | -1.82 | -1.71 | -1.68 | -1.69 | -1.55 | -1.49 |
EBITDA | -61.37M | -58.85M | -59.09M | -63.23M | -63.11M | -63.26M | -63.1M | -60.12M | -58.78M | -55.96M | -55.25M | -54.15M | -53.42M | -52.75M | -50.96M | -48.2M | -43.6M | -40.23M | -33.7M | -28.49M | -24.38M | -20.03M |
EBIT | -62.15M | -59.64M | -59.79M | -63.67M | -63.57M | -63.72M | -63.56M | -60.6M | -59.25M | -56.52M | -55.8M | -54.7M | -53.96M | -53.3M | -51.63M | -48.76M | -44.11M | -40.58M | -33.89M | -28.61M | -24.46M | -20.08M |
Depreciation & Amortization | 779.4K | 786.79K | 698.89K | 445.22K | 455.33K | 461.34K | 466.29K | 476.86K | 466.2K | 561.86K | 548.18K | 552.24K | 542.02K | 550.87K | 667.65K | 530.88K | 493.05K | 325.81K | 159.07K | 114.02K | 82.11K | 52.92K |
Add to Watchlist
Select watchlists to add or remove IMRX